 | |
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C13H19N |
| Molar mass | 189.302 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
6-(2-Aminopropyl)tetralin (6-APT), also sometimes calledtetralinylaminopropane (TAP), is adrug of theamphetamine class which acts as aselective serotonin releasing agent (SSRA).[1] It hasIC50 values of 121 nM, 6,436 nM, and 3,371 nM forinhibiting thereuptake ofserotonin,dopamine, andnorepinephrine, respectively.[1] Though it possesses an appreciablein vitro profile, in animaldrug discrimination studies it was not found to substitute forMMAI oramphetamine and to only partially substitute forMBDB.[1] This parallelsAlexander Shulgin's finding thatEDMA (the1,4-benzodioxineanalogue of 6-APT) is limitedlyactive,[2] and appears to indicate that thepharmacokinetics of both EDMA and 6-APT may not be favorable.[1]
